Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl

NCT06089707 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Naloxone Nasal Spray

Sponsor

Johns Hopkins University

Collaborators

[object Object]